These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16382369)

  • 1. Phospholamban gene mutations are not associated with hypertrophic cardiomyopathy in a Northern Greek population.
    Kalemi T; Efthimiadis G; Zioutas D; Lambropoulos A; Mitakidou A; Giannakoulas G; Vassilikos V; Karvounis H; Kotsis A; Parharidis G; Louridas G
    Biochem Genet; 2005 Dec; 43(11-12):637-42. PubMed ID: 16382369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholamban gene mutations are not associated with hypertrophic cardiomyopathy in patients from southern Poland.
    Petkow-Dimitrow P; Kieć-Wilk B; Kwaśniak M; Mikołajczyk M; Dembińska-Kieć A
    Kardiol Pol; 2011; 69(2):134-7. PubMed ID: 21332051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
    Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
    Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
    Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy.
    Millat G; Bouvagnet P; Chevalier P; Dauphin C; Jouk PS; Da Costa A; Prieur F; Bresson JL; Faivre L; Eicher JC; Chassaing N; Crehalet H; Porcher R; Rodriguez-Lafrasse C; Rousson R
    Eur J Med Genet; 2010; 53(5):261-7. PubMed ID: 20624503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy.
    Kabaeva ZT; Perrot A; Wolter B; Dietz R; Cardim N; Correia JM; Schulte HD; Aldashev AA; Mirrakhimov MM; Osterziel KJ
    Eur J Hum Genet; 2002 Nov; 10(11):741-8. PubMed ID: 12404107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy.
    Wang SX; Fu CY; Zou YB; Wang H; Shi Y; Xu XQ; Chen JZ; Song XD; Huan TJ; Hui RT
    Chin Med J (Engl); 2008 Jan; 121(1):27-31. PubMed ID: 18208662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide gene polymorphism is not associated with hypertrophic cardiomyopathy.
    Xue H; Wang H; Wang XJ; Sun K; Wang SX; Song XD; Hui RT
    Chin Med J (Engl); 2010 Jan; 123(2):188-92. PubMed ID: 20137368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy.
    Olson TM; Doan TP; Kishimoto NY; Whitby FG; Ackerman MJ; Fananapazir L
    J Mol Cell Cardiol; 2000 Sep; 32(9):1687-94. PubMed ID: 10966831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.
    Doolan A; Tebo M; Ingles J; Nguyen L; Tsoutsman T; Lam L; Chiu C; Chung J; Weintraub RG; Semsarian C
    J Mol Cell Cardiol; 2005 Feb; 38(2):387-93. PubMed ID: 15698845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid heart disease mimicking hypertrophic cardiomyopathy.
    Mörner S; Hellman U; Suhr OB; Kazzam E; Waldenström A
    J Intern Med; 2005 Sep; 258(3):225-30. PubMed ID: 16115295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy.
    DeWitt MM; MacLeod HM; Soliven B; McNally EM
    J Am Coll Cardiol; 2006 Oct; 48(7):1396-8. PubMed ID: 17010801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases: summary of the literature and implications for genetic testing.
    Landstrom AP; Adekola BA; Bos JM; Ommen SR; Ackerman MJ
    Am Heart J; 2011 Jan; 161(1):165-71. PubMed ID: 21167350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation screening of the PTPN11 gene in hypertrophic cardiomyopathy.
    Limongelli G; Hawkes L; Calabro R; McKenna WJ; Syrris P
    Eur J Med Genet; 2006; 49(5):426-30. PubMed ID: 16488201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardin gene regulatory variants as surrogate markers of cardiac hypertrophy - study in a genetically homogeneous population.
    Kontaraki JE; Parthenakis FI; Patrianakos AP; Karalis IK; Vardas PE
    Clin Genet; 2008 Jan; 73(1):71-8. PubMed ID: 18028454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene.
    Villard E; Duboscq-Bidot L; Charron P; Benaiche A; Conraads V; Sylvius N; Komajda M
    Eur Heart J; 2005 Apr; 26(8):794-803. PubMed ID: 15769782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected mutations in the myosin binding protein C gene in the Polish population of patients with hypertrophic cardiomyopathy.
    Rudziński T; Selmaj K; Drozdz J; Krzemińska-Pakuła M
    Kardiol Pol; 2008 Aug; 66(8):821-5; discussion 826-7. PubMed ID: 18803133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling.
    Ingles J; Doolan A; Chiu C; Seidman J; Seidman C; Semsarian C
    J Med Genet; 2005 Oct; 42(10):e59. PubMed ID: 16199542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.